Evidence map›Paper›PMID 26549199›Full record

ArticleMolecular medicine reports2016

Hippocampal mitogen-activated protein kinase activation is associated with intermittent hypoxia in a rat model of obstructive sleep apnea syndrome.

Ya-Ning Zhao, Hong-Yang Wang, Jian-Min Li, Bao-Yuan Chen, Guo Xia, Pan-Pan Zhang, Yan-Lei Ge

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Spatial and temporal expression of SP-B and TGF-β1 in hyperoxia-induced neonatal rat lung injury.International journal of clinical and experimental pathology · 2018
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ya-Ning ZhaoDepartment of Rehabilitation, Affiliated Hospital of Hebei United University, Tangshan, Hebei 063000, P.R. China.
Hong-Yang WangDepartment of Respiratory Medicine, Affiliated Hospital of Hebei United University, Tangshan, Hebei 063000, P.R. China.
Jian-Min LiDepartment of Respiratory Medicine, Affiliated Hospital of Hebei United University, Tangshan, Hebei 063000, P.R. China.
Bao-Yuan ChenDepartment of Respiratory Medicine, Affiliated Hospital of Hebei United University, Tangshan, Hebei 063000, P.R. China.
Guo XiaDepartment of Respiratory Medicine, Affiliated Hospital of Hebei United University, Tangshan, Hebei 063000, P.R. China.
Pan-Pan ZhangDepartment of Rehabilitation, Affiliated Hospital of Hebei United University, Tangshan, Hebei 063000, P.R. China.
Yan-Lei GeDepartment of Respiratory Medicine, Affiliated Hospital of Hebei United University, Tangshan, Hebei 063000, P.R. China.
North China University of Science and Technology · CNAffiliated Hospital of Hebei University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive sleep apnea syndrome (OSAS), characterized by intermittent hypoxia/re‑oxygenation, may impair the cerebral system. Although mitogen‑activated protein kinase (MAPK) signaling was observed to have a key role in hypoxia‑induced brain injury, the intracellular events and their underlying mechanisms for intermittent hypoxia/re‑oxygenation-associated damage to hippocamal MAPKs, including extracellular signal‑regulated kinase (ERK)1/2, P38MAPK and c‑Jun N‑terminal kinase (JNK) remain to be elucidated and require further investigation. A total of five rats in each sub‑group were exposed to intermittent hypoxia or continued hypoxia for 2, 4, 6 or 8 weeks. Histological, immunohistochemical and biological analyses were performed to assess nerve cell injury in the hippocampus. Surviving CA1 pyramidal cells were identified by hematoxylin and eosin staining. The levels of phosphorylated ERK1/2, P38MAPK and JNK were detected by western blotting. B‑cell lymphoma 2 (Bcl‑2) and Bcl‑2‑associated X protein (Bax) in neural cells were examined by immunohistochemistry. The malondialdehyde (MDA) contents and superoxide dismutase (SOD) activities were measured by thiobarbituric acid and xanthine oxidation methods, respectively. Under continued hypoxia, the levels of phospho‑ERK1/2 peaked at the fourth week and then declined, whereas phospho‑P38MAPK and JNK were detected only in the late stages. By contrast, under intermittent hypoxia, ERK1/2, P38MAPK and JNK were activated at all time-points assessed (2, 4, 6 and 8 weeks). The levels of phospho‑ERK1/2, P38MAPK and JNK were all higher in the intermittent hypoxia groups than those in the corresponding continued hypoxia groups. Bcl‑2 was mainly increased and reached the highest level at six weeks in the continued hypoxia group. Of note, Bcl‑2 rapidly increased to the peak level at four weeks, followed by a decrease to the lowest level at the eighth week in the intermittent hypoxia group. Bax was generally increased at the late stages under continued hypoxia, but increased at all time-points under the intermittent hypoxia conditions. The two types of hypoxia induced an increase in the MDA content, but a decrease in SOD activity. Marked changes in these two parameters coupled with markedly reduced surviving cells in the hippocampus in a time‑dependent manner were observed in the intermittent hypoxia group in comparison with the continued hypoxia group. OSAS‑induced intermittent hypoxia markedly activated the MAPK signaling pathways, which were triggered by oxidative stress, leading to abnormal expression of downstream Bcl‑2 and Bax, and a severe loss of neural cells in the hippocampus.

Indexed as

Animalsbcl-2-Associated X ProteinBlood Gas AnalysisBlotting, WesternCA1 Region, HippocampalCell SurvivalDisease Models, AnimalEnzyme ActivationExtracellular Signal-Regulated MAP KinasesHippocampusHypoxiaImmunohistochemistryJNK Mitogen-Activated Protein KinasesMaleMalondialdehydeMitogen-Activated Protein Kinasesbcl-2-Associated X ProteinExtracellular Signal-Regulated MAP KinasesJNK Mitogen-Activated Protein KinasesMalondialdehydeMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesSuperoxide Dismutase

Identifiers

PMID26549199
PMCPMC4686116
OpenAlexW2127211546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.